Amgen | SCHULD



Debt Veränderung Datum
AbbVie USD 69.89B 2.74B 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 72.68M 72.68M 2025-06
Amgen USD 57.38B 2.72B 2025-03
Biogen USD 6.59B 296.8M 2025-06
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Eli Lilly USD 38.52B 4.87B 2025-03
Exelixis USD 179.84M 179.84M 2025-06
Genmab DKK 143M 886M 2025-03
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 17.35B 1.08B 2025-06
Glaxosmithkline GBP 16.99B 927M 2024-12
Incyte USD 42.41M 5.29M 2025-06
Ionis Pharmaceuticals USD 1.42B 169.27M 2025-06
J&J USD 52.25B 15.62B 2025-03
Merck USD 34.84B 2.27B 2025-03
Moderna USD 745M 683M 2025-03
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Novartis USD 31.27B 12M 2025-03
Novartis USD 31.26B 828M 2024-12
Pfizer USD 62.11B 2.24B 2025-03
PTC Therapeutics USD 2.4B 17.29M 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 21.05B 3.14B 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Takeda JPY 4.51T 9.32B 2025-06
Teva Pharmaceutical Industries USD 16.65B 1.43B 2025-03
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12


Amgen SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.